Amneal Pharmaceuticals, Inc.
AMRX
Revenue
701.78M
▲42.59M▲6.46%
3 Months ChangeAssets
3.51B
▲53.53M▲1.55%
3 Months ChangeLiabilities
0.00
0.000.00%
3 Months ChangeFree Cash Flow
-13.61M
▼-143.63M▼-110.47%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-01
Form 8-K
ID: 0001628280-24-041646
2024-08-09
Form 10-Q
ID: 0001723128-24-000032
2024-08-09
Form 8-K
ID: 0001723128-24-000030
2024-05-08
Form 10-Q
ID: 0001723128-24-000021
2024-05-07
Form 8-K
ID: 0001628280-24-021107
2024-05-03
Form 8-K
ID: 0001723128-24-000018
2024-03-01
Form 8-K
ID: 0001723128-24-000007
2024-01-10
Form 8-K
ID: 0001723128-24-000003
2023-12-15
Form 8-K
ID: 0001193125-23-296658
2023-11-14
Form 8-K
ID: 0001193125-23-277184